A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women
about
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveThe role of oxidative stress and inflammation in cardiovascular agingAtrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes.C-reactive protein levels in the brugada syndrome.Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants.B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes.Multiple inflammatory biomarker detection in a prospective cohort study: a cross-validation between well-established single-biomarker techniques and an electrochemiluminescense-based multi-array platformChronic Inflammation: Accelerator of Biological Aging.Type 2 diabetes mellitus and risk of incident atrial fibrillation in women.Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation.Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.Age of natural menopause and atrial fibrillation: the Framingham Heart Study.Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC StudyChronic Kidney Disease and the Risk of New-Onset Atrial Fibrillation: A Meta-Analysis of Prospective Cohort Studies.Relation of renal function to risk for incident atrial fibrillation in women.Determinants of Left Atrial Volume in Patients with Atrial Fibrillation.Atrial fibrillation is associated with hematopoietic tissue activation and arterial inflammationRisk factors for incident atrial fibrillation with and without left atrial enlargement in women.Novel genetic markers improve measures of atrial fibrillation risk prediction.Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation.Advanced Left Atrial Remodeling and Appendage Contractile Dysfunction in Women Than in Men Among the Patients With Atrial Fibrillation: Potential Mechanism for Stroke.The risk of atrial fibrillation in patients with rheumatoid arthritisImpact of Atrial Fibrillation On Cardiovascular Mortality in the Setting of Myocardial Infarction.Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins.Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease.Bridging the gender gap in atrial fibrillation.Inflammation and the pathogenesis of atrial fibrillation.CHA2DS2-VASc Score: A Predictor of Thromboembolic Events and Mortality in Patients With an Implantable Monitoring Device Without Atrial Fibrillation.Role of tumor necrosis factor alpha in the pathogenesis of atrial fibrillation: A novel potential therapeutic target?Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation.Heart rate, heart rate variability and inflammatory biomarkers among young and healthy adults.Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib.Estimated glomerular filtration rate within the normal or mildly impaired range and incident non-valvular atrial fibrillation: Results from a population-based cohort study.The interrelationships of birthweight, inflammation and body composition in healthy adults.Increased risk of atrial fibrillation in patients with coeliac disease: a nationwide cohort study.Inflammation, blood pressure and cardiovascular disease: heading east.Association of lipoprotein-associated phospholipase A2 and risk of incident atrial fibrillation: Findings from 3 cohorts.Stroke in atrial fibrillation and improving the identification of 'high-risk' patients: the crossroads of immunity and thrombosis.Atrial fibrillation
P2860
Q24594814-4270B7A5-0BF4-44A7-8370-706B7FA1E677Q26864987-DE948916-2991-4F5A-9B04-B795A1585641Q30234626-440355DB-8610-4391-B8BD-F1C64C28808EQ33160813-3C4EFA3D-F6F9-4416-B5AD-0FFFA6C7A675Q33721705-DEEDBE4C-C0B8-4FE8-BC28-D52553EBE591Q34342621-7150E291-0A2D-498C-8A5C-CCD1FC7B67BFQ34603226-4F7CFAA6-0466-470C-840E-8A9AD23BE980Q34615040-691D0D8A-539E-4A4A-B773-000526A3C221Q34680346-23C32A7A-DBF4-473C-8C9E-07B87BFB430BQ34779355-DE6265C3-CE0A-4E8D-BE1F-83B67F4083A4Q35021968-38A948E7-6BD5-408C-B4C1-804C85A47769Q35609742-705AAFE2-A7B3-403D-B941-9440A7BFE691Q35908462-DCDAA838-0BCD-4E20-A56F-12C779B34ABDQ35913178-2B20D069-0C6E-4659-A6A5-EB0F69FE9EB6Q36016780-29B60F89-26CE-40F4-BD18-7DA1069C5975Q36108990-02C8518D-DD64-4CD5-BB93-1B0707962002Q36152831-BE73BBE3-83CD-4E74-8996-C5C5B3780FD9Q36514164-07053F0C-9A1D-4B28-A083-9B7CF72B9F60Q36815158-420F83D2-AC6E-4A52-83C2-CD871B5FF992Q37061256-9D1572B0-8891-4A13-872A-ED0938D98EDCQ37118899-03B9A5B1-AA75-4ECA-877F-9F6CBE31CCEAQ37240656-5966036C-8F2C-484A-BB64-6AE40CF298FBQ37446317-7BE8C6A3-B723-4134-B52E-FC67463B9D5CQ37496133-B0A111CC-ED74-4CC1-90C0-CE79BF8A365FQ37602866-A1AB5ED3-769E-44DB-BFFD-A9AF7B5F3BCCQ38065252-4DB92E63-4CF7-4E29-B725-3D9F16D9F67CQ38317687-79B4D6F3-A628-420F-B999-8FC02657FD88Q38333088-0D22758E-C7D7-491D-BF3D-1E08A484DAF2Q38372615-FD6CF8E4-0ECB-41EC-9ED9-10CE5727E84BQ38486305-60BB676D-1893-4E32-AAB7-EAC19AE58FB4Q38738095-62286A1D-49ED-4554-A9A1-93699AFE713AQ38861510-B865AD44-8FDC-4B8C-BC40-CCCE83F97158Q39683930-39A71C05-11E3-4BD3-BB2E-CE6456E9BD81Q40502984-8619DA82-0479-43C5-90CD-E4D0371377ABQ40908186-0A4295E2-932D-4C66-83EF-F5133451C015Q42604095-8EF289B7-4409-470C-9CCF-6669F6DA2668Q44303150-95DB0562-FB58-44D8-9011-FE652A5D3EB8Q49972109-904B2528-651D-4999-873D-13094B85D1D3Q53836636-23ED36F9-EE56-48DF-80FC-4929E57472FEQ56607936-C74BD503-AF6B-46D5-BC70-ABE2AEF9A731
P2860
A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A multimarker approach to asse ...... f atrial fibrillation in women
@ast
A multimarker approach to asse ...... f atrial fibrillation in women
@en
type
label
A multimarker approach to asse ...... f atrial fibrillation in women
@ast
A multimarker approach to asse ...... f atrial fibrillation in women
@en
prefLabel
A multimarker approach to asse ...... f atrial fibrillation in women
@ast
A multimarker approach to asse ...... f atrial fibrillation in women
@en
P2093
P2860
P356
P1476
A multimarker approach to asse ...... f atrial fibrillation in women
@en
P2093
Brendan M Everett
Christine M Albert
David Conen
Lynda Rose
Nancy R Cook
Paul M Ridker
Usha B Tedrow
P2860
P304
P356
10.1093/EURHEARTJ/EHQ146
P577
2010-05-25T00:00:00Z